About Haleon
Haleon is a publicly listed company based in Weybridge (United Kingdom) founded in 2022. It operates as an oral care, respiratory, and pharmaceutical products are manufactured by Haleon. Its chief executive is Brian Mcnamara. Its website haleon.com draws about 208 thousand monthly visits. Haleon offers products and services including Consumer Health Products and ESG and Impact Services. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Haleon plc.
Company details
Haleon was founded in 2022 and is headquartered in Weybridge, United Kingdom. Operations focus on the pharmaceutical sector, where oral care, respiratory, and other health products are produced. In its inaugural year, annual revenues of 13.5 billion were achieved, alongside a net profit of 1.33 billion. Leadership is provided by CEO Brian McNamara, with activities centered on global manufacturing and distribution.
- Annual Revenue$14.85 B (USD)-1.81as on Dec 31, 2025
- Net Profit$2.25 B (USD)15.6as on Dec 31, 2025
- EBITDA$3.96 B (USD)3.95as on Dec 31, 2025
Products & Services of Haleon
Haleon offers a comprehensive portfolio of products and services, including Consumer Health Products and ESG and Impact Services.
Products for everyday health needs are provided by Haleon across various categories to support global consumers
Services related to health inclusivity and environmental efforts are offered by Haleon to promote societal benefits
Apps and channels of Haleon
its YouTube channel Haleon has 1.93K subscribers and 30 videos.
Videos from Haleon
The most watched videos on Haleon's YouTube channel, Haleon (1.93K subscribers). Click a video to play it here.
More on Haleon.
People of Haleon
1099 people are tracked at Haleon (399 in leadership, 10 in board & advisors, 690 in team).
| Name | Role | Group |
|---|---|---|
Brian Mcnamara | CEO | Leadership |
Lalitendu S Sahu | Director - Architect - Data And Analytics On Azure | Leadership |
Tomokazu Imai | Finance Director, North Asia | Leadership |
Surya Adhi Saputra | Country Digital And Technology Head For Indonesia, Philippines & Thailand | Leadership |
Andreea Mihalcea | Training Business Partner - Director | Leadership |
Kristine Smagris | Talent Acquisition Partner | Leadership |
Leandro O. Gelpke | Regional Head Of Digital And Technology Latin America | Leadership |
Sylvain Bonnet Garcia | Vp, Head Of Strategy, Performance & Portfolio - EMEA & Latam | Leadership |
Benlembarek | Director Of Operations | Leadership |
Brice Valton | EHS & Engineering Director | Leadership |
Daniel Osmar de Jesus | Director Of Engineering | Leadership |
Amritpal Singh Assi | Global Head Of Data Analytics & Product | Leadership |
Tim Koubek | Transformation Program Director | Leadership |
Matthieu Delacour | Data Product Director | Leadership |
Kamal B. | Product Tech Partner - Data & Analytics | Leadership |
Maxim Rogatch | Head Of Ecommerce | Leadership |
Malovika Verma | TA Partner | Leadership |
Madiha Zubair | Head Of Human Resources | Leadership |
Fiona Renzi-Fantin | Head Of Quality Supply Chain (qsc) - Canada | Leadership |
Philippe Khoury | Head Of Sales Lebanon & Jordan | Leadership |
1079 more people are available in the full profile.
Complete people profiles for Haleon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Haleon
Haleon is a publicly listed company on the LSE with ticker symbol HLN in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jul 2022
- Listed onLSE: HLN
- Listed entityHaleon PLC
- Exchange sectorHealth technology
- ISINGB00BMX86B70
- Share price357.20 GBX (+0.59% on the day) · 2026-10-14
- Market capitalisation31,232,034,356.00 GBX
- Price to earnings19.7
- EPS (diluted, trailing year)0.18 GBX
- Dividend yield2.06%
- Volume (last session)2,325,236
Financials of Haleon
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 11.03B GBP | 1.67B GBP | 2.94B GBP |
| 2024 | 11.23B GBP | 1.44B GBP | 2.83B GBP |
| 2023 | 11.30B GBP | 1.05B GBP | 2.81B GBP |
| 2022 | 10.86B GBP | 1.06B GBP | 2.72B GBP |
| 2021 | 9.54B GBP | 1.39B GBP | 2.22B GBP |
Detailed financial statements for Haleon
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Haleon
The website of Haleon (haleon.com) receives about 208K visits a month and ranks #172,812 among all websites worldwide, #2,400 in Financial Planning and Management.
- Monthly visits208K
▼ 1.5% vs previous month
- Unique visitors98.1K
per month
- Global rank#172,812
among all websites
- Category rank#2,400
Finance · Financial Planning and Management
- Bounce rate41%
- Pages per visit3.6
- Average visit1 min 14 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Haleon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| experianplc.com | 100% | – | #517,090 | View details | |
| investegate.co.uk | 100% | 287.8K | #170,396 | View details | |
| davaindia.com | 60% | 121K | #262,189 | View details | |
| wellnessforever.com | 60% | 480.8K | #74,529 | View details | |
| enterohealthcare.com | 60% | 17.8K | #1,535,138 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Haleon
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as Haleon (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Haleon
Complete news archive for Haleon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haleon
Haleon was founded in 2022.
Haleon is headquartered in Weybridge, United Kingdom.
Brian Mcnamara is the current CEO of Haleon.
Annual revenue of Haleon is $14.85B as on Dec 31, 2025.
Haleon was founded in 2022 and is headquartered in Weybridge, United Kingdom. Operations focus on the pharmaceutical sector, where oral care, respiratory, and other health products are produced. In its inaugural year, annual revenues of 13.5 billion were achieved, alongside a net profit of 1.33 billion. Leadership is provided by CEO Brian McNamara, with activities centered on global manufacturing and distribution.
Haleon offers Consumer Health Products and ESG and Impact Services.
Yes, Haleon is publicly traded on LSE under the ticker symbol HLN.
Haleon operates through Haleon Plc.
The website of Haleon receives about 208 thousand visits a month and ranks #172,812 among all websites worldwide.